Background Maternal rectovaginal colonization with group B Streptococcus (GBS) is the
most common pathway for GBS disease in mother, fetus, and newborn. This article, the …

Abstract Background Group B Streptococcus (GBS) remains a leading cause of neonatal
sepsis in high-income contexts, despite declines due to intrapartum antibiotic prophylaxis …

Background Natural history studies have correlated serotype-specific anti–capsular
polysaccharide (CPS) IgG in newborns with a reduced risk of group B streptococcal disease …

Summary Background Group B streptococcus (GBS) colonisation during pregnancy can
lead to invasive GBS disease (iGBS) in infants, including meningitis or sepsis, with a high …

Background Although meningitis is largely preventable, it still causes hundreds of thousands
of deaths globally each year. WHO set ambitious goals to reduce meningitis cases by 2030 …

Background We aimed to provide the first comprehensive estimates of the burden of group B
Streptococcus (GBS), including invasive disease in pregnant and postpartum women, fetal …

Invasive disease due to group B Streptococcus infection (Streptococcus agalactiae) results
in a wide spectrum of clinical disease. In North America, serotypes Ia, Ib, II, III, and V are …

Background Preterm birth complications are the leading cause of deaths among children< 5
years of age. Studies have suggested that group B Streptococcus (GBS) maternal …

Background Survivors of infant group B streptococcal (GBS) disease are at risk of
neurodevelopmental impairment (NDI), a burden not previously systematically quantified …

Background Early-onset group B streptococcal disease (EOGBS) occurs in neonates (days 0–
6) born to pregnant women who are rectovaginally colonized with group B Streptococcus …